PIEZO2 and neoplasm: Knockout of Piezo2 resulted in a compromised BBTB, as shown by intratumoural accumulation of systemically administered 1kDa Cadaverine and 70kDa Dextran (51), and extended survival in response to etoposide treatment compared to tumor-bearing controls.